Medical News

RSS

Boston Scientific launches Innova Self-Expanding Bare-Metal Stent System in Europe

Boston Scientific Corporation announces CE Mark and European market launch of the Innova Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions in arteries above the knee, specifically the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The company plans to launch the product immediately in Europe and other CE Mark countries.

14 May 2012

Genetic cause of rare genetic disorder, Hamamy syndrome

Scientists at A*STAR's Institute of Medical Biology (IMB), in collaboration with doctors and scientists in Jordan, Turkey, Switzerland and USA, have identified the genetic cause of a birth defect known as Hamamy syndrome .

14 May 2012

Doctors turn to blood pressure tests in kids, BMI tests in adults to fight obesity

Doctors and insurers are considering how best to combat obesity in America including screening kids early via blood pressure checks and using body mass index tests in adults to monitor weight and potential problems.

14 May 2012

FDA clears MAQUET's new MEGA larger volume intra-aortic balloon catheters

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new MEGA 7.5Fr. 30cc and 40cc intra-aortic balloon (IAB) catheters. These new, larger volume catheters will allow clinicians to provide patients with greater hemodynamic support, regardless of their height.

14 May 2012

New Jefferson Hepatitis C Center

Thomas Jefferson University Hospital recently opened its new Jefferson Hepatitis C Center, one of only a few comprehensive, multidisciplinary centers dedicated to the study of hepatitis C virus and hepatic disease in the Pennsylvania, New Jersey and Delaware tri-state area.

14 May 2012

Researchers barcode different strains of influenza virus and HRSV

Dr Julian Hiscox and Dr John Barr of the University's Faculty of Biological Sciences are working with the Health Protection Agency Porton (HPA) to build a bank of molecular signatures that will help identify the severity of virus infection from characteristic changes seen in cells. Currently the team is barcoding different strains of influenza virus and human respiratory syncytial virus (HRSV) - a virus associated with the onset of asthma in young children.

14 May 2012

Important role played by nurse helplines

A survey by Cancer Research UK's helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.

14 May 2012

Accretive gives detailed response to Sen. Franken inquiry

The Minnesota attorney general says the company has some overly-aggressive billing and collection practices.

14 May 2012

ESIM announces ‘Excellence in Integrative Medicine Research Awards’

The European Society for Integrative Medicine (ESIM), with support from Heel, announces a new international research prize in integrative medicine: the "Excellence in Integrative Medicine Research Award." Applicants are asked to submit papers by May 30, 2012.

14 May 2012

MedNPV, SurgLine partner to supply low cost spinal orthopedic implants

Thomas Toland, CEO of SGLN and SurgLine, Inc. announced today it has signed an agreement with MedNPV, LLC, a well-established management company and surgical group operator with business throughout the state of California. The agreement between the parties will permit SurgLine to supply its' low cost spinal orthopedic implants.

14 May 2012

First Edition: May 14, 2012

In today's headlines, a report about how the Ryan budget plan -- specifically, its Medicare changes -- is playing in congressional races.

14 May 2012

Soligenix first quarter revenues decrease to $647,418

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.

14 May 2012

College Park Family Care Center chooses eClinicalWorks comprehensive EHR solution

eClinicalWorks, a market leader in ambulatory clinical systems, today announces that College Park Family Care Center, the largest non-hospital owned multi-specialty group in the Kansas City-area, has chosen eClinicalWorks comprehensive electronic health records (EHR) solution for its 91 providers across 12 locations.

14 May 2012

Amcom Software certifies on Siemens Enterprise Communications OpenScape Voice platform

Demonstrating its commitment to the healthcare industry, Siemens Enterprise Communications today announced that Amcom Software has been certified on its OpenScape Voice platform, allowing healthcare enterprises to easily leverage Amcom console platforms with the OpenScape portfolio for next-generation clinical communications.

14 May 2012

Encision fourth quarter revenue increases to $3.370 million

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, today announced financial results for its fiscal 2012 fourth quarter and fiscal year ended March 31, 2012.

14 May 2012

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.

14 May 2012

mTOR protein plays a key role in development of diabetes

The signaling protein mTOR is a key regulator that controls cell growth. Dysfunction of mTOR increases not only the likelihood of developing cancer but also diabetes. In the current issue of the journal Cell Metabolism, Mike Hall and his team from the Biozentrum of the University of Basel describe how inhibition of mTOR signaling can impair carbohydrate metabolism and potentially lead to diabetes.

14 May 2012

ReCor completes enrollment in PARADISE system clinical study for 'resistant' hypertension

ReCor Medical, an emerging medical device company, announced today that it has completed enrollment in the REDUCE 15-patient pilot clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.

14 May 2012

Toshiba’s Aquilion ONE CT system improves detection of acute stroke

Kaleida Health's Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.'s Aquilion ONE CT system in diagnosing acute stroke.

14 May 2012

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.

14 May 2012